Aardvark Therapeutics Statistics
Total Valuation
AARD has a market cap or net worth of $21.88 million. The enterprise value is -$37.89 million.
Important Dates
The last earnings date was Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AARD has 21.88 million shares outstanding. The number of shares has increased by 43.78% in one year.
| Current Share Class | 21.88M |
| Shares Outstanding | 21.88M |
| Shares Change (YoY) | +43.78% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 15.77% |
| Owned by Institutions (%) | 25.78% |
| Float | 12.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.11 |
| Quick Ratio | 8.58 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.85% and return on invested capital (ROIC) is -52.44%.
| Return on Equity (ROE) | -80.85% |
| Return on Assets (ROA) | -73.48% |
| Return on Invested Capital (ROIC) | -52.44% |
| Return on Capital Employed (ROCE) | -131.51% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.60M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -89.84% |
| 50-Day Moving Average | 3.43 |
| 200-Day Moving Average | 5.41 |
| Relative Strength Index (RSI) | 29.54 |
| Average Volume (20 Days) | 1,707,073 |
Short Selling Information
The latest short interest is 1.04 million, so 4.75% of the outstanding shares have been sold short.
| Short Interest | 1.04M |
| Short Previous Month | 553,262 |
| Short % of Shares Out | 4.75% |
| Short % of Float | 8.42% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -75.97M |
| Pretax Income | -72.76M |
| Net Income | -72.76M |
| EBITDA | -75.93M |
| EBIT | -75.97M |
| Earnings Per Share (EPS) | -$3.33 |
Full Income Statement Balance Sheet
The company has $60.35 million in cash and $572,000 in debt, with a net cash position of $59.78 million or $2.73 per share.
| Cash & Cash Equivalents | 60.35M |
| Total Debt | 572,000 |
| Net Cash | 59.78M |
| Net Cash Per Share | $2.73 |
| Equity (Book Value) | 57.61M |
| Book Value Per Share | 2.63 |
| Working Capital | 57.07M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -66.81M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 42,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -66.81M |
| FCF Per Share | -$3.05 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AARD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -43.78% |
| Shareholder Yield | -43.78% |
| Earnings Yield | -333.16% |
| FCF Yield | -305.30% |
Analyst Forecast
The average price target for AARD is $4.00, which is 300.00% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.00 |
| Price Target Difference | 300.00% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |